Literature DB >> 24677538

AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.

Igor Grigoriev1, Wolfgang zu Castell, Philipp Tsvetkov, Alexey V Antonov.   

Abstract

BACKGROUND: Exploration of the Adverse Event Reporting System (AERS) data by a wide scientific community is limited due to several factors. First, AERS data must be intensively preprocessed to be converted into analyzable format. Second, application of the currently accepted disproportional reporting measures results in false positive signals.
METHODS: We proposed a data mining strategy to improve hypothesis generation with respect to potential associations.
RESULTS: By numerous examples, we illustrate that our strategy controls the false positive signals. We implemented a free online tool, AERS spider (www.chemoprofiling.org/AERS).
CONCLUSIONS: We believe that AERS spider would be a valuable tool for drug safety experts.
Copyright © 2014 John Wiley & Sons, Ltd.

Keywords:  AERS; FDA; data mining; pharmacoepidemiology; pharmacovigilance

Mesh:

Year:  2014        PMID: 24677538     DOI: 10.1002/pds.3561

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

Review 1.  Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.

Authors:  Joshua B French; Maurizio Bonacini; Marwan Ghabril; David Foureau; Herbert L Bonkovsky
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

2.  Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.

Authors:  Mayur Sarangdhar; Scott Tabar; Charles Schmidt; Akash Kushwaha; Krish Shah; Jeanine E Dahlquist; Anil G Jegga; Bruce J Aronow
Journal:  Nat Biotechnol       Date:  2016-07-12       Impact factor: 54.908

3.  A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports.

Authors:  Keith B Hoffman; Mo Dimbil; Nicholas P Tatonetti; Robert F Kyle
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

Review 4.  Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems.

Authors:  Ivano Amelio; Vivien Landré; Richard A Knight; Andrey Lisitsa; Gerry Melino; Alexey V Antonov
Journal:  Oncotarget       Date:  2015

5.  OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.

Authors:  Ruwen Böhm; Leocadie von Hehn; Thomas Herdegen; Hans-Joachim Klein; Oliver Bruhn; Holger Petri; Jan Höcker
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

6.  A Primer to the Structure, Content and Linkage of the FDA's Manufacturer and User Facility Device Experience (MAUDE) Files.

Authors:  Lisa Garnsey Ensign; K Bretonnel Cohen
Journal:  EGEMS (Wash DC)       Date:  2017-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.